$12.39
Today
as of Sep 4, 16:49 ET
Last 30 days
Recent Press Releases & News
Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views
Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?
Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ...
Overview
52-week range
$5.65
$13
89% of range
Avg surprise (last 3)
+44.4%
Avg reaction (last 2)
+19.9%
100% positive
Latest IV / EM
98%
EM ±18.7% · $13 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.05 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $0.01 | $-0.02 | +150.0% | +125.0% | +36.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.02 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.11 | $-0.06 | -83.3% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.04 | $-0.12 | +66.7% | — | +3.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.21 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.41 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.21 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.23 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18M | $15M | — | $12M | $10M | $9M | — | $7M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $2M | $-119,000 | — | $-189,000 | $-3M | $-808,000 | — | $-5M |
| Net income | $2M | $201,000 | — | $-638,000 | $-3M | $-1M | — | $-6M |
| EPS (diluted) | $0.05 | $0.01 | — | $-0.02 | $-0.11 | $-0.04 | — | $-0.21 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $41M | $40M | $37M | $22M | $19M | $23M | $27M | $40M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $72M | $67M | $67M | $46M | $41M | $43M | $44M | $58M |
| Total assets | $76M | $72M | $71M | $49M | $45M | $46M | $45M | $59M |
| Long-term debt | — | — | — | $19M | $19M | $19M | — | $32M |
| Total liabilities | $33M | $34M | $35M | $54M | $52M | $52M | $51M | $64M |
| Total equity | $42M | $38M | $35M | $-4M | $-7M | $-6M | $-6M | $-5M |